M

    MEDIFAST INC (MED)

    Official site

    CONSUMER CYCLICAL • PERSONAL SERVICES • NYSE

    $12.15
    -0.03 (-0.25%)

    Market Cap: $136.18M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    85%(34/40)
    Avg Surprise
    +28.65%
    Streak
    2 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.35
    Range$-0.35 - $-0.35
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.62-77.1%
    60d ago$-0.62-77.1%
    30d ago$-0.62-77.1%
    7d ago$-0.62-77.1%
    Current$-0.35
    Revenue Consensus
    $71M
    Range$71M - $71M
    1 analysts
    Dec 31, 2026
    EPS Consensus$0.37
    Range$0.37 - $0.37
    1 analysts
    Revenue Consensus
    $75M
    Range$75M - $75M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.37---
    Sep 26EST
    		-$-0.35---
    Jun 26
    		$-0.28N/A+58.21%Beat-227.3%
    Mar 26
    		$-0.19N/A+63.46%Beat-171.4%
    Dec 25
    		$-1.65$-0.45-266.67%Miss-1750.0%
    Sep 25
    		$-0.21$-0.36+41.67%Beat-160.0%
    Jun 25
    		$0.22$-0.19+215.79%Beat-76.1%
    Mar 25
    		$-0.07N/A+72.00%Beat-110.6%
    Dec 24
    		$0.10N/A-58.75%Miss-81.8%
    Sep 24
    		$0.35$-0.28+225.00%Beat-83.5%
    Jun 24
    		$0.92$0.39+135.90%Beat-66.8%
    Mar 24
    		$0.66$0.80-17.50%Miss-82.0%
    Dec 23
    		$0.55$0.96-42.71%Miss-83.2%
    Sep 23
    		$2.12$1.07+98.13%Beat-36.1%
    Jun 23
    		$2.77$1.44+92.36%Beat-28.4%
    Mar 23
    		$3.67$2.40+52.92%Beat+2.2%
    Dec 22
    		$3.27$2.22+47.30%Beat+12.4%
    Sep 22
    		$3.32$1.91+73.82%Beat-6.7%
    Jun 22
    		$3.87$3.23+19.81%Beat-2.3%
    Mar 22
    		$3.59$3.57+0.56%Beat+3.8%
    Dec 21
    		$2.91$2.65+9.81%Beat+23.3%
    Sep 21
    		$3.56$2.92+21.92%Beat+22.3%
    Jun 21
    		$3.96$3.30+20.00%Beat+102.0%
    Mar 21
    		$3.46$2.72+27.21%Beat+79.3%
    Dec 20
    		$2.36$2.38-0.84%Miss+42.2%
    Sep 20
    		$2.91$2.49+16.87%Beat+120.5%
    Jun 20
    		$1.96$1.84+6.52%Beat+12.0%
    Mar 20
    		$1.93$1.33+45.11%Beat+13.5%
    Dec 19
    		$1.66$1.08+53.70%Beat+27.7%
    Sep 19
    		$1.32$1.33-0.75%Miss+15.8%
    Jun 19
    		$1.75$1.72+1.74%Beat+50.9%
    Mar 19
    		$1.70$1.53+11.11%Beat+68.3%
    Dec 18
    		$1.30$1.21+7.44%Beat+116.7%
    Sep 18
    		$1.14$1.14+0.00%Beat+107.3%
    Jun 18
    		$1.16$0.98+18.37%Beat+84.1%
    Mar 18
    		$1.01$0.86+17.44%Beat+98.0%
    Dec 17
    		$0.60$0.48+25.00%Beat+76.5%
    Sep 17
    		$0.55$0.51+7.84%Beat+7.8%
    Jun 17
    		$0.63$0.52+21.15%Beat-
    Mar 17
    		$0.51$0.47+8.51%Beat-
    Dec 16
    		$0.34$0.33+3.03%Beat-
    Sep 16
    		$0.51$0.45+13.33%Beat-

    Dividends

    Dividend Metrics

    Yield0.00%
    Annual/Share$0.00
    Payout Ratio0.00%
    Frequency4
    View MED's full dividend history

    Key Metrics

    Valuation
    P/E Ratio-5.21EV/EBITDA0.05x
    Price/FCF33.71xFCF Yield2.97%
    Profitability
    Profit Margin-8.08%Operating Margin-5.66%
    ROE-12.40%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio4.86xQuick Ratio4.35x
    Trading Statistics
    Beta0.70Avg Volume182.29K
    52-Week High$14.6752-Week Low$9.22

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$11.93
    SMA 20$11.96
    SMA 50$11.01
    SMA 200$11.16
    EMA 10$11.98
    EMA 20$11.72
    EMA 50$11.39
    EMA 200$11.53

    MACD

    Line: 0.32Signal: 0.29Hist: 0.03

    ADX

    ADX: 29.8+DI: 27.6-DI: 15.1

    Aroon & PSAR

    Aroon Up24.0
    Aroon DownN/A
    PSAR$10.68

    Bollinger Bands

    Upper Band$12.85
    Lower Band$11.06
    %B Position1493%(Upper)
    Band Width0.61

    RSI (14-Day)

    Neutral
    59.9

    Momentum Oscillators

    Stoch %K65.8
    Stoch %D62.7
    Williams %R-32.1
    ROC (10d)6.2%
    Momentum0.71
    CCI (20d)29.3
    MFI (14d)54.7

    Volatility Measures

    ATR (14d)$0.49(4.0%)
    StdDev (20d)0.45
    Hist Vol128.5%(High)

    Volume Flow

    VWAP$12.14
    OBV-8.4M
    AD Line-1.3M
    CMF (20d)-0.053

    Volume Metrics

    Avg Vol (20d)178.9K
    Vol Ratio0.7x
    VWMA (20d)$12.25

    Pivot Points

    R3$13.06
    R2$12.75
    R1$12.47
    Pivot Point$12.16
    S1$11.88
    S2$11.57
    S3$11.29

    Advanced Oscillators

    TSI16.47
    Ultimate Osc45.5
    KST123.03

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$76.38M$76.04M$75.10M$89.41M$105.56M$115.73M$119.00M$140.16M$168.56M$174.74M$191.01M$235.87M
    Cost of Revenue$22.99M$24.29M$22.96M$27.25M$28.91M$31.48M$30.78M$34.49M$45.12M$47.45M$49.65M$58.49M
    Gross Profit$53.40M$51.76M$52.14M$62.16M$76.64M$84.25M$88.22M$105.67M$123.44M$127.29M$141.37M$177.38M
    Operating Expenses$57.72M$55.05M$59.94M$66.24M$77.71M$85.51M$87.51M$103.57M$131.31M$119.35M$132.69M$151.87M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$57.72M$55.05M$59.94M$66.24M$77.71M$85.51M$87.51M$103.57M$131.31M$119.35M$132.69M$151.87M
    Operating Income$-4,327,000$-3,295,000$-7,804,000$-4,081,000$-1,066,000$-1,262,000$708,000$2.11M$-7,876,000$7.94M$8.68M$25.51M
    Interest Income$1.35M$1.38M$1.42M$1.43M$1.37M$1.30M$952,000$1.33M$1.30M$1.22M$1.18M$1.03M
    Interest Expense$0$0$0$0$0$0$0$528,000$2.77M$0$0$0
    Income Before Tax$-2,991,000$-1,941,000$-6,383,000$-2,657,000$2.88M$526,000$1.27M$1.58M$-10,650,000$11.59M$9.80M$26.55M
    Income Tax Expense$109,000$181,000$11.74M$-396,000$395,000$1.30M$474,000$449,000$-2,496,000$3.27M$3.77M$3.42M
    Net Income$-3,100,000$-2,122,000$-18,119,000$-2,261,000$2.48M$-772,000$800,000$1.13M$-8,154,000$8.32M$6.04M$23.13M
    EBITDA$-1,042,000$-1,000$-4,494,000$-1,146,000$5.38M$2.31M$3.32M$3.20M$-9,060,000$13.43M$11.81M$28.93M
    EBIT$-4,338,000$-3,320,000$-7,803,000$-4,083,000$1.51M$-775,000$322,000$245,000$-11,946,000$10.36M$8.63M$25.52M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MED

    News

    MED | Medifast, Inc. Financials - Revenue Breakdown

    This article provides a financial overview of Medifast, Inc. (MED), focusing on its revenue breakdown. It details congressional trading activity involving MED, insider trading data, institutional holdings, and key financial statements, but notes the absence of specific segment or geographical revenue data. The company is described as a health and wellness firm known for its OPTAVIA program, addressing obesity and promoting a healthy lifestyle.

    Quiver Quantitative•8/23/26•
    Neutral

    Medifast director Parsa Kiai acquires $842,698 in company shares By Investing.com

    Medifast director Parsa Kiai recently acquired shares in the company totaling $842,698 through indirect transactions on August 19 and August 20, 2026. The stock is currently trading at $11.95, and InvestingPro analysis suggests it may be undervalued despite the company not being profitable over the last twelve months. This comes after Medifast reported better-than-expected Q2 2026 financial results, with a smaller loss per share and higher revenue than anticipated.

    Investing.com Nigeria•8/22/26•
    Bullish

    Medifast director Parsa Kiai acquires $842,698 in company shares

    Medifast director Parsa Kiai recently acquired $842,698 worth of company shares through indirect transactions on August 19 and August 20, 2026. The shares were purchased via Steamboat Capital Partners Master Fund, LP and Steamboat Capital Partners II, LP, where Kiai serves as Managing Member. Despite impressive gross profit margins, Medifast has not been profitable over the last twelve months, though it recently surpassed Q2 2026 financial expectations.

    Investing.com•8/22/26•
    Somewhat-Bullish

    Medifast Inc (MDF) Q4 2025 Earnings Report - Results, Call & Slides

    Medifast (MDF) reported its Q4 2025 earnings, beating analyst expectations for both EPS and revenue. The company posted an actual EPS of -€0.48 against a consensus of -€0.71, and actual revenue of €64.95M compared to an expected €61.76M. Medifast's next earnings report is estimated for November 9, 2026.

    TipRanks•8/22/26•
    Neutral

    Medifast (NYSE: MED) sees Steamboat Capital build 790,693-share stake

    Steamboat Capital Partners, LLC and its managing member, Parsa Kiai, have reported a 7.1% ownership stake in Medifast (NYSE: MED), beneficially owning 790,693 shares of common stock. This stake, acquired for approximately $8.36 million, was funded through open-market purchases using client working capital, potentially including margin loans. Recent significant purchases include shares bought on August 19 and August 20, 2026.

    Stock Titan•8/21/26•
    Neutral

    Frequently Asked Questions About MED

    Does MED pay dividends?
    MEDIFAST INC (MED) has a dividend payment track record. See the MED dividend history page for its current payment status, yield, and streaks.
    What is MED's market cap?
    MEDIFAST INC (MED) has a market capitalization of $136.18M with a current stock price of $12.15.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In